Baxter
Baxter (BAX): Bank on blood products
“Baxter International (NYSE: BAX) benefits from a robust balance sheet, solid operating momentum, and rising earnings estimates,” says Richard Moroney.
In Dow Theory Forecasts, he explains, “The first company to commercially prepare intravenous treatments, Baxter has manufactured and distributed medical products since 1931.” Here’s his bullish review of the stock.
“The first company to commercially prepare intravenous treatments, Baxter [...]
Search
Latest Headlines
- A Different Kind Of WarEvaluate Iraq on its own terms. […]
- China's Hidden Local DebtPeople who own shares in Chinese banks will get stuck with the losses. […]
- America's Foreign-Owned National DebtIs it a threat to the U.S. economy? […]
- Home-Equity Loans: What You Need To KnowWhy do consumers decide to use this form of credit? […]
- Six Steps To Stop Fighting Over MoneyIt's the top reason for divorce. Find out how to stop these disagreements. […]
New Stocks Live provides the latest stock news.
